The Commonwealth Serum Laboratories was established in Australia in 1916.
At CSL, Corporate Responsibility is about conducting our business ethically.
We offer the broadest range of quality plasma-derived and recombinant therapies in the industry.
CSL Seqirus opened in 2015 and is the second largest influenza company in the world.
We support collaborative innovation through the endowment of awards and grants to researchers around the world.
Our product portfolio focuses on innovation in new products
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL.
View our ASX announcements
Visit this page to see all of our current news releases
We announced our Half Year Financial Results for the period ending 31st December 2020 on Thursday, 18th February 2021 (AEDT). Full details including a link to the webcast presentation, are available via the link below.
Popular search terms:
Americas
Asia Pacific
MIddle East
Europe
Middle East
